$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$4.40M
Market Cap
0.0097
P/E Ratio
788.8
EPS
$114.00
52 Week High
$4.93
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
CNS Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Houston, Texas, focused on developing innovative therapies for brain and central nervous system tumors. The company is advancing its lead candidate aimed at addressing substantial unmet medical needs in oncology, particularly within neuro-oncology. Through a robust scientific foundation and strategic collaborations, CNS Pharmaceuticals is committed to enhancing patient outcomes and tackling the complexities of brain cancer treatment. With its pioneering approach, the company is positioning itself as a key player in the specialized field of neuro-oncology therapeutics.
LPTX
KIND
IVP
F
KVUE
KAVL
ADAP
WOK
HOOD
RR
NIO
BYND
PFE
NVDA
ASBP
PLTD
QBTS
RIG
AMD
CDE
SNAP
MTSR
FI
AVGO
NOK
MSFT
HBAN
CCL
UBER
KO
WULF
SOUN
CNQ
VZ
CLSK
CAN
EOSE
FCX
CGC
MSTR
CFLT
IONQ
MU
CX
AMCR
SLB
ITUB
TSLG
MDLZ
NKE
JOBY
TSLA
NVTS
TSM
XOM
ASTS
INTC
KEY
CPNG
LYFT
SHOT
ZAPP
RXRX
KHC
WRBY
KDP
LPTX
KIND
IVP
F
KVUE
KAVL
ADAP
WOK
HOOD
RR
NIO
BYND
PFE
NVDA
ASBP
PLTD
QBTS
RIG
AMD
CDE
SNAP
MTSR
FI
AVGO
NOK
MSFT
HBAN
CCL
UBER
KO
WULF
SOUN
CNQ
VZ
CLSK
CAN
EOSE
FCX
CGC
MSTR
CFLT
IONQ
MU
CX
AMCR
SLB
ITUB
TSLG
MDLZ
NKE
JOBY
TSLA
NVTS
TSM
XOM
ASTS
INTC
KEY
CPNG
LYFT
SHOT
ZAPP
RXRX
KHC
WRBY
KDP